Related Experiment Video
Updated: Jun 28, 2026
23:53
Ole Isacson: Development of New Therapies for Parkinson's Disease
Published on: April 29, 2007
Physical therapy in Parkinson's disease: evolution and future challenges.
Samyra H J Keus1, Marten Munneke, Maarten J Nijkrake
1Parkinson Center Nijmegen (ParC), Department of Neurology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Summary
Physical therapy plays a crucial role in managing mobility issues for Parkinson's disease (PD) patients. Emerging research confirms its effectiveness, with ongoing efforts to integrate evidence-based care into clinical practice.
Area of Science:
- Neurology
- Rehabilitation Medicine
- Physical Therapy Research
Background:
- Parkinson's disease (PD) significantly impacts patient mobility despite optimal medical and surgical treatments.
- Physical therapy is essential for addressing progressive mobility challenges in PD.
- The field of physical therapy for PD has seen substantial growth and scientific validation.
Purpose of the Study:
- To review the evolution and scientific validation of physical therapy in Parkinson's disease.
- To identify current research trends, challenges, and future directions in PD physical therapy.
- To discuss strategies for implementing evidence-based care for all PD patients.
Main Methods:
- Structured literature review of trials and systematic reviews on physical therapy for PD.
- Consultation with experts in the field of physical therapy for PD.
- Analysis of the historical development and current state of research.
Main Results:
- The quantity and quality of clinical trials for physical therapy in PD have rapidly increased since 1981.
- Evidence-based guidelines for physical therapy in PD were established in 2004.
- High-quality evidence supports specific physical therapy strategies, including fall prevention.
Conclusions:
- Research in physical therapy for PD is a developing field with emerging high-quality evidence.
- Future research should focus on specific interventions and implementation into clinical practice.
- Innovative strategies are needed to improve allied health care organization and accessibility for PD patients.
Related Concept Videos
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...